“The company is planning to commence the proposed rights offering in August of
2017 in order to raise equity capital in a timely and cost-effective manner,
while providing its shareholders the opportunity to participate. The
commencement and expiration dates of the rights offering will be included in
the prospectus supplement to be filed with the Securities and Exchange
Commission at the commencement of the proposed rights offering.
The company intends to use the net proceeds from the proposed rights offering
to (i) expand clinical, sales and marketing initiatives to accelerate adoption
of the Ekso in the rehabilitation market and broaden the Ekso footprint into
Asia, (ii) to increase research, development and commercialization activities
with respect to an Ekso robotic exoskeleton for home use, and/or (iii) in the
development and commercialization of able-bodied exoskeletons for industrial
use, and for working capital and other general corporate purposes.”
So basically puissance Capital main purpose is to target Asia countries. They see the value in this company.